Clinical Trials
31 trialsNCT06724835 2024-12-09
Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)
Shenzhen Celconta Life Science Co., Ltd.
Phase 1 Unknown
NCT05893368 2024-04-24
PERGIQUAL
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Unknown
NCT06375707 2024-04-19
Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT06338605 2024-03-29
CYSTATINcDK4/6
Erasmus Medical Center
Unknown
NCT06047184 2023-09-21
Phase I Study of BEBT-209 in Women With Advanced Breast Cancer
BeBetter Med Inc
Phase 1 Unknown
NCT04304352 2023-06-28
VEX
European Institute of Oncology
Phase 2 Unknown
NCT05775575 2023-03-20
A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown
NCT05753865 2023-03-03
A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT05469750 2022-07-22
Dalpiciclib Plus Letrozole and Capecitabine
Fujian Medical University Union Hospital
Phase 2 Unknown
NCT05439499 2022-07-06
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Ahon Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT05438810 2022-07-05
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Ahon Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT03071926 2022-04-20
Metronomic PLD in Patients With Primary Endocrine Resistant ABC
Fudan University
Phase 2 Unknown
NCT05337657 2022-04-20
A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer
Genor Biopharma Co., Ltd.
Phase 1 Unknown
NCT05274893 2022-03-11
A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT05255523 2022-02-24
Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer
Fujian Medical University Union Hospital
Phase 2 Unknown
NCT05156619 2022-01-25
Health Care Disparities in Culturally Diverse, Special Needs & Disadvantaged Populations - Bridging the Gap
Hadassah Medical Organization
Unknown
NCT05047848 2021-09-17
Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer
Liaoning Cancer Hospital & Institute
Phase NA Unknown
NCT05020964 2021-08-25
Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib
ChineseAMS
Phase 2 Unknown
NCT03538171 2021-07-09
Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer
Taizhou EOC Pharma Co., Ltd.
Phase 3 Unknown
NCT03927456 2021-06-03
A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT03966898 2021-06-02
A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT04856371 2021-04-23
Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer
Haihe Biopharma Co., Ltd.
Phase 1 Unknown
NCT03125746 2021-01-05
A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Phase 1 Unknown
NCT03182634 2019-01-22
plasmaMATCH
Institute of Cancer Research, United Kingdom
Phase 2 Unknown
NCT03282825 2018-01-23
Clinical Study of Decitabine and Paclitaxel Combination Therapy
Dong Wha Pharmaceutical Co. Ltd.
Phase 1 Unknown
NCT03047889 2017-02-09
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
ChineseAMS
Unknown
NCT01931943 2013-08-30
A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT01311037 2011-12-13
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
King Faisal Specialist Hospital & Research Center
Unknown
NCT00874146 2010-09-02
Level of HER2-neu Gene Amplification an Response to Trastuzumab
Istituto Clinico Humanitas
Unknown
NCT00915369 2010-02-08
A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer
Fresenius Kabi Oncology Ltd.
Phase 1 Unknown
NCT00717951 2008-07-25
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer
Academy Military Medical Science, China
Phase 2 Unknown